These 19 “Moaty” Small-Caps Are High-Quality & Undervalued
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
“All of these companies are working on new drugs that could be worth billions, and successes with them would push their stock prices through the…
While vaccine makers have gotten most of the attention in the biotech sector over the past year, the author of today’s article advises that other…
“We are seeing an opportunity for massive profits in stocks under $10 a share,” declares the author of today’s article, who explains that “As so…
A company that produces slot machines and provides financial equipment and services to casinos, a provider of cloud-based, business-critical communications and storage messaging services, and a broadband provider…
“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…
The FDA’s approval of Biogen’s Alzheimer’s drug “has set a precedent, showing a much easier path to approval for investigative drug treatments focused on neurodegenerative…
With the current excitement surrounding heavily shorted stocks, the author of today’s article takes a look at a number of current and former penny stocks…
A regenerative medicine company focused on developing, manufacturing and commercializing product solutions for the advanced wound care, surgical, and sports medicine markets in the U.S.…
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” states the author of today’s…